Mitsubishi Tanabe Pharma Corp (4508.T)
4508.T on Tokyo Stock Exchange
2,002JPY
11:30am IST
2,002JPY
11:30am IST
Change (% chg)
¥0 (+0.00%)
¥0 (+0.00%)
Prev Close
¥2,002
¥2,002
Open
¥2,003
¥2,003
Day's High
¥2,003
¥2,003
Day's Low
¥2,002
¥2,002
Volume
1,164,100
1,164,100
Avg. Vol
1,687,790
1,687,790
52-wk High
¥2,010
¥2,010
52-wk Low
¥1,128
¥1,128
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2020 | Sep | 89,997.00 | 2.561 |
| Jun | 98,112.00 | 12.270 | |
| FY 2019 | Mar '19 | 92,288.00 | -7.304 |
| Dec | 122,769.00 | 29.382 | |
| Sep | 104,359.00 | 19.672 | |
| Jun | 105,351.00 | 24.890 | |
| FY 2018 | Mar '18 | 94,542.00 | 10.441 |
| Dec | 125,957.00 | 39.731 | |
| Sep | 105,648.00 | 22.905 | |
| Jun | 107,708.00 | 30.270 | |
| FY 2017 | Mar '17 | 99,625.00 | 19.728 |
| Dec | 120,237.00 | 42.602 | |
| Sep | 98,622.00 | 25.658 | |
| Jun | 105,493.00 | 39.044 |
*Note: Units in Millions ofYen
**Note: Units in Yen
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Mar-19 | 1 | 103,300.00 | 103,300.00 | 103,300.00 | -- |
| Quarter Ending Mar-20 | 1 | 88,500.00 | 88,500.00 | 88,500.00 | -- |
| Year Ending Mar-19 | 7 | 432,697.00 | 436,500.00 | 426,000.00 | -- |
| Year Ending Mar-20 | 4 | 393,978.00 | 443,000.00 | 375,912.00 | 431,622.00 |
| Year Ending Mar-21 | 4 | 394,575.00 | 447,000.00 | 367,800.00 | 427,147.00 |
| Earnings (per share) | |||||
| Quarter Ending Mar-19 | 1 | 13.80 | 13.80 | 13.80 | -- |
| Year Ending Mar-19 | 8 | 72.25 | 88.27 | 41.89 | -- |
| Year Ending Mar-20 | 5 | 29.04 | 86.70 | 9.81 | 90.02 |
| Year Ending Mar-21 | 4 | 20.19 | 25.68 | 9.80 | 83.67 |
| LT Growth Rate (%) | 1 | -44.19 | -44.19 | -44.19 | -6.84 |
Sales and Profit Figures in Japanese Yen (JPY);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | 54.24 | 35.75 | 37.18 | |
| P/E High - Last 5 Yrs. | 29.28 | 43.47 | 47.09 | |
| P/E Low - Last 5 Yrs. | 18.25 | 24.44 | 25.31 | |
| Beta | 0.51 | 0.99 | 0.96 | |
| Price to Sales (TTM) | 2.79 | 3.80 | 5.19 | |
| Price to Book (MRQ) | 1.27 | 4.18 | 4.52 | |
| Price to Tangible Book (MRQ) | 1.91 | 4.99 | 5.65 | |
| Price to Cash Flow (TTM) | 39.50 | 21.22 | 22.19 | |
| % Owned Institutions | -- | 0.00 | 0.00 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | 2.80 | 1.74 | 1.63 | |
| Dividend Yield - 5 Year Avg | 2.55 | 1.59 | 1.50 | |
| Dividend 5 Year Growth Rate | 6.96 | 6.89 | 7.20 | |
| Payout Ratio(TTM) | 151.77 | 154.78 | 137.78 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | -13.76 | 16.58 | 16.80 | |
| Sales (TTM) vs TTM 1 Yr. Ago | -6.29 | 11.86 | 11.74 | |
| Sales - 5 Yr. Growth Rate | 0.58 | 5.31 | 5.92 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | -86.98 | 22.03 | 19.15 | |
| EPS (TTM) vs TTM 1 Yr. Ago | -61.04 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -3.81 | 6.16 | 7.30 | |
| Capital Spending - 5 Yr. Growth Rate | -7.89 | 7.38 | 7.73 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | 5.76 | 2.64 | 2.64 |
| Current Ratio (MRQ) | 6.64 | 3.74 | 3.71 |
| LT Debt to Equity (MRQ) | 0.02 | 13.98 | 15.63 |
| Total Debt to Equity (MRQ) | 0.02 | 16.83 | 19.06 |
| Interest Coverage (TTM) | -- | 109.85 | 100.73 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | 54.60 | 54.09 | 54.32 | |
| Gross Margin - 5 Yr. Avg. | 60.43 | 53.10 | 53.36 | |
| EBITD Margin (TTM) | 10.31 | -- | -- | |
| EBITD - 5 Yr. Avg | 20.83 | 18.63 | 16.21 | |
| Operating Margin (TTM) | 7.03 | 13.94 | 7.64 | |
| Operating Margin - 5 Yr. Avg. | 16.52 | 14.33 | 11.44 | |
| Pre-Tax Margin (TTM) | 6.89 | 13.14 | 7.08 | |
| Pre-Tax Margin - 5 Yr. Avg. | 17.48 | 14.69 | 11.67 | |
| Net Profit Margin (TTM) | 3.78 | 9.83 | 3.69 | |
| Net Profit Margin - 5 Yr. Avg. | 11.75 | 11.04 | 8.08 | |
| Effective Tax Rate (TTM) | 45.14 | 21.15 | 21.28 | |
| Effective Tax Rate - 5 Yr. Avg. | 32.80 | 23.12 | 24.84 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 55,778,360 | 992,908,521 | 864,808,103 | |
| Net Income/Employee (TTM) | 2,107,499 | 114,319,287 | 99,533,610 | |
| Receivable Turnover (TTM) | 3.37 | 5.36 | 5.63 | |
| Inventory Turnover (TTM) | 2.39 | 2.73 | 3.69 | |
| Asset Turnover (TTM) | 0.38 | 0.90 | 0.88 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | 1.43 | 10.93 | 10.64 | |
| Return on Assets - 5 Yr. Avg. | 5.10 | 11.46 | 11.03 | |
| Return on Investment (TTM) | 1.59 | 13.53 | 13.19 | |
| Return on Investment - 5 Yr. Avg. | 5.73 | 14.48 | 13.92 | |
| Return on Equity (TTM) | 2.31 | 14.57 | 14.45 | |
| Return on Equity - 5 Yr. Avg. | 6.35 | 15.67 | 15.38 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | -2.09 | -0.08 | 0.58 |
| EPS (TTM) % | -35.52 | -14.26 | -3.81 |
| Dividend % | 0.00 | 6.78 | 6.96 |
Note: Units in Millions of US Dollars
Performance for Mitsubishi Tanabe Pharma Corp
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | 50.71 | 49.93 | 99 | 69 |
| 13 Week | 71.93 | 52.10 | 99 | 26 |
| 26 Week | 55.15 | 39.38 | 99 | 73 |
| 52 Week | 16.45 | 12.76 | 99 | 41 |
| YTD | 26.69 | 11.13 | 99 | 52 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 18.09% |
| # of Holders: | 240 |
| Total Shares Held: | 101,568,410 |
| 3 Mo. Net Change: | 7,879,979 |
| # New Positions: | 5 |
| # Closed Positions: | 7 |
| # Increased Positions: | 52 |
| # Reduced Positions: | 57 |
| # Net Buyers: | -5 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.